Dr. Zerelda Esquer Garrigos, assistant professor in the Division of Infectious Diseases, co-authored a Scientific Statement from the American Heart Association published August 31, 2022 in Circulation regarding Management of Infective Endocarditis (IE) in people who inject drugs. The statement, prompted by an unprecedented increase in incidence of IE among people who inject drugs, highlights the importance of taking a multidisciplinary approach to improve outcomes, including infectious disease, cardiology, cardiac surgery, addiction medicine, pharmacy, and social work. The writing group also advocates for 6 weeks of intravenous antibiotics for all patients with IE and, if not feasible, gives alternative oral treatment options. The group also recommends that patients with IE who inject drugs should be considered for heart valve repair or replacement regardless of current drug use if they have indications for surgery. Read the full article here.